GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Structural heart occlusion devices market in Europe to grow at 6% CAGR through 2036, forecasts GlobalData

Europe’s structural heart occlusion devices market is expected to grow steadily, driven by rising prevalence of atrial fibrillation (AF), greater stroke-risk awareness, and wider adoption of minimally invasive left atrial appendage (LAA) occlusion procedures. Increasing physician experience with transcatheter procedures and improvements in device design are also expected to expand patient eligibility. Amid these trends, […]
Read more

Zoom continues to enhance platform and position itself well for the future, says GlobalData

Zoom continues to enhance its platform with wide-ranging improvements, expanding the ZoomMate AI assistant with new models and languages alongside a redesigned Contact Center workspace. Fulfilling the company’s vision and extending its corporate transformation, these collaboration trends position the company well for the future, keeping it poised for further development, according to GlobalData, a leading […]
Read more

CDMOs invest in European API capabilities to balance changing demand and supply chain risks, says GlobalData

Contract development and manufacturing organizations (CDMOs) are ramping up their active pharmaceutical ingredient (API) investments in Europe. A series of recent deals shows how companies are strengthening their infrastructure in the region, as they position themselves to develop and supply newer, more complex medicines, says GlobalData, a leading intelligence and productivity platform. GlobalData’s monthly Bio/Pharmaceutical […]
Read more

AI climate benefits struggle to compete with rising environmental footprint, warns GlobalData

Artificial intelligence’s (AI) climate benefits risk being overstated as surging data center emissions and water consumption threaten to outpace efficiency gains. While predictive AI can deliver measurable reductions across energy, agriculture, and buildings, the environmental cost of generative AI remains substantial, with limited evidence that its climate benefits can offset its footprint, says GlobalData, a […]
Read more

Cyber insurance gap leaves UK property businesses dangerously exposed, reveals GlobalData

Cyber insurance remains underpenetrated among the UK real estate and renting businesses, despite cyberattacks against UK property services companies increasing by 17% in 2025. A combination of rising cyber exposure and relatively low insurance uptake is leaving a significant proportion of property businesses financially exposed to cyber incidents, reveals GlobalData, a leading intelligence and productivity […]
Read more

Slackforce Surfaces strengthens Slackbot’s role as an AI-powered enterprise interface, says GlobalData

Slackforce Surfaces marks a significant advance in AI-enabled enterprise collaboration, turning Slackbot into a practical interface for live business data and context. By automatically creating and refreshing dashboards, reports, presentations, and other views, the capability can reduce the friction of gathering information while helping users derive deeper insights and make faster, more informed decisions, says […]
Read more

AI emerges as growing competitive threat to UK commercial brokers, reveals GlobalData

UK commercial brokers are increasingly recognizing artificial intelligence (AI) as a competitive threat, as conversational AI creates new ways for customers to research insurance and obtain pricing without initially engaging a broker, according to a survey by GlobalData, a leading intelligence and productivity platform.  GlobalData’s 2026 UK Commercial Broker Survey* found that 9.2% of brokers […]
Read more

Lunsekimig results bolster Sanofi’s strategy to defend respiratory franchise ahead of Dupixent patent expiry, says GlobalData

Lunsekimig’s Phase IIb asthma data strengthen its case as a differentiated next-generation biologic, with dose-dependent reductions in exacerbations and improvements in lung function supporting progression into Phase III. The results could sharpen Sanofi’s strategy to defend its respiratory franchise ahead of Dupixent’s patent expiry, while intensifying competition in an increasingly crowded asthma biologics market, says […]
Read more

Tozorakimab results broaden biologic treatment across COPD population, says GlobalData

Tozorakimab’s (interleukin-33 (IL-33) inhibitor) Phase III chronic obstructive pulmonary disease (COPD) results strengthen the case for a new class of biologic treatment that could extend beyond eosinophil-defined patients. Consistent efficacy across OBERON and TITANIA trials, including those with low eosinophil counts, could broaden the addressable COPD population and intensify competition in a market where current […]
Read more

Vodafone TV will boost VodafoneThree’s UK fixed-mobile multiplay push but needs sharper differentiation, says GlobalData

Vodafone TV’s October 2026 launch will strengthen VodafoneThree’s UK fixed-mobile convergence strategy by filling a key pay-TV gap and extending TV access to mobile-only customers. The move could accelerate multiplay adoption and support 5G+ and broadband cross-selling, but the British telco needs stronger operator-specific benefits and bundled incentives to establish a compelling proposition in an […]
Read more

PPPs reshape Gulf infrastructure delivery as governments expand private-sector participation, says MEED, a GlobalData company

Dubai, UAE — 11September 2026: Public-private partnerships (PPPs) are becoming an important mechanism for infrastructure delivery across the Middle East and North Africa, with the Gulf Cooperation Council (GCC) leading the shift as governments diversify their economies and expand private-sector participation, reveals MEED, the Middle East-focused business intelligence platform of GlobalData Plc. The growth of […]
Read more

Jascayd mortality data strengthens case for earlier treatment of IPF and PPF, says GlobalData

New mortality data for Jascayd (nerandomilast) strengthens the case for earlier treatment of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), showing meaningful survival benefits among patients with preserved lung function. The findings could reshape payer and prescribing decisions, supporting broader first-line use in Europe while giving Boehringer Ingelheim (BI) a stronger commercial narrative […]
Read more

Foreign CMOs expand US capacity as pharma supply chains regionalize, reveals GlobalData

Foreign contract manufacturing organizations (CMOs) are accelerating investment in US manufacturing as pharmaceutical companies prioritize supply-chain resilience, regional capacity and greater control over production. The recent site upgrades, acquisitions and new partnerships signal a shift from cost-driven outsourcing toward integrated, locally anchored models, giving sponsors broader access to end-to-end capabilities while reducing exposure to geopolitical, […]
Read more

India card payments to rise steadily as financial inclusion deepens and credit cards gain traction, says GlobalData

India’s payment card usage is set to gradually rise over the coming years. This upward trend is firmly underpinned by a steadily growing banked population across the country. Furthermore, the improving payments infrastructure and consumers’ increasing preference for electronic payments over traditional cash transactions are heavily driving this significant shift toward a completely digital economy, […]
Read more

Apple China hiring signals AI push, says GlobalData

Apple is deepening its technology and operational capabilities in China, with recent hiring spanning artificial intelligence (AI) and machine learning alongside data infrastructure, supply chain, privacy and export compliance. The breadth of recruitment signals a strategic shift toward building a more integrated technology ecosystem, reinforcing China’s role in Apple’s innovation, operations and regional business strategy, […]
Read more

Harvey Nichols can bounce back under Frasers Group, says GlobalData

The contrasting fortunes of Harrods, Harvey Nichols, Fenwick and John Lewis & Partners highlights how sharply the UK department store channel is diverging. While Harrods has returned to profit, Fenwick is showing early signs of a turnaround and John Lewis & Partners is undergoing a strategic reset under new leadership. Harvey Nichols, by contrast, is […]
Read more

UK VC funding value soars 113% YoY despite flat deal activity during January–July 2026, finds GlobalData

The UK’s venture capital (VC) ecosystem demonstrated remarkable resilience during the first seven months (January–July) of 2026, recording a more than two-fold (113%) expansion year-on-year (YoY) in total capital deployed despite stagnant deal volume, reveals GlobalData, a leading intelligence and productivity platform. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The trend suggests a pronounced shift […]
Read more

Daraxonrasib approval changes standard of care in second-line pancreatic cancer, says GlobalData

The US FDA approval of Revolution Medicine’s Rasonque (daraxonrasib) changes the standard of care in second-line pancreatic cancer, as the oral therapy will displace the intensive and complicated-to-administer chemotherapy regimens currently used in practice, revealsGlobalData, a leading intelligence and productivity platform. Israel Stern, Healthcare Senior Analyst at GlobalData, comments. “Unlike first-generation RAS inhibitors, that only bind […]
Read more
1 2 3 … 206